BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Financials | 5.47% |
| 3 | Healthcare | 4.96% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Ternium
TX
$10.7B
| $273K | ﹤0.01% |
12,415
-5,635
| -31% | -$115K |
|
|
CVET
2702
DELISTED
Covetrus, Inc. Common Stock
CVET
| $272K | ﹤0.01% |
20,605
+2,909
| +16% | +$35.2K |
|
|
EPZM
2703
DELISTED
Epizyme, Inc
EPZM
| $270K | ﹤0.01% |
10,961
-2,762
| -20% | -$41K |
|
|
AKS
2704
DELISTED
AK Steel Holding Corp
AKS
| $268K | ﹤0.01% |
81,586
-136,571
| -63% | -$379K |
|
2705
CALL
Hewlett Packard
HPE
$79.2B
| $268K | ﹤0.01% |
169
| – | – |
|
|
2706
PUT
Hewlett Packard
HPE
$79.2B
| $268K | ﹤0.01% |
169
| – | – |
|
|
BHVN
2707
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $267K | ﹤0.01% |
4,911
-858
| -15% | -$42.5K |
|
2708
Kearny Financial
KRNY
$604M
| $267K | ﹤0.01% |
19,276
+3,547
| +23% | +$49K |
|
2709
V2X
VVX
$2.55B
| $265K | ﹤0.01% |
5,169
+240
| +5% | +$11.6K |
|
2710
Marcus Corp
MCS
$929M
| $265K | ﹤0.01% |
8,337
+5,019
| +151% | +$170K |
|
|
MNTV
2711
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $263K | ﹤0.01% |
14,724
-2,518
| -15% | -$44.3K |
|
|
NTUS
2712
DELISTED
Natus Medical Inc
NTUS
| $263K | ﹤0.01% |
7,973
+2,352
| +42% | +$75.4K |
|
2713
Southside Bancshares
SBSI
$984M
| $263K | ﹤0.01% |
7,074
+1,966
| +38% | +$69.5K |
|
|
AEGN
2714
DELISTED
Aegion Corp
AEGN
| $263K | ﹤0.01% |
11,741
+6,008
| +105% | +$130K |
|
2715
United Natural Foods
UNFI
$2.94B
| $262K | ﹤0.01% |
29,871
+17,696
| +145% | +$143K |
|
2716
National Bank Holdings
NBHC
$1.94B
| $262K | ﹤0.01% |
7,426
+2,230
| +43% | +$78.6K |
|
2717
St. Joe Company
JOE
$3.89B
| $261K | ﹤0.01% |
13,187
+6,948
| +111% | +$129K |
|
2718
Zoom
ZM
$32.2B
| $261K | ﹤0.01% |
3,843
-23,818
| -86% | -$1.64M |
|
2719
Hilltop Holdings
HTH
$2.28B
| $261K | ﹤0.01% |
10,473
-2,831
| -21% | -$69.1K |
|
|
ARQL
2720
DELISTED
Arqule Inc
ARQL
| $260K | ﹤0.01% |
13,023
-5,094
| -28% | -$59.1K |
|
|
FARO
2721
DELISTED
Faro Technologies
FARO
| $259K | ﹤0.01% |
5,140
+1,990
| +63% | +$97.2K |
|
2722
Champion Homes
SKY
$5.23B
| $258K | ﹤0.01% |
8,141
+634
| +8% | +$19.8K |
|
2723
Bank of Montreal
BMO
$129B
| $258K | ﹤0.01% |
3,326
| – | – |
|
|
CMD
2724
DELISTED
Cantel Medical Corporation
CMD
| $257K | ﹤0.01% |
3,619
-2,332
| -39% | -$169K |
|
2725
Chefs' Warehouse
CHEF
$4.57B
| $256K | ﹤0.01% |
6,722
+3,154
| +88% | +$115K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.